Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Prepaid Assets: 2020-2024

Historic Prepaid Assets for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Dec 2024 value amounting to $18.1 million.

  • Maravai Lifesciences Holdings' Prepaid Assets fell 33.38% to $14.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.4 million, marking a year-over-year decrease of 33.38%. This contributed to the annual value of $18.1 million for FY2024, which is 4.24% down from last year.
  • Per Maravai Lifesciences Holdings' latest filing, its Prepaid Assets stood at $18.1 million for FY2024, which was down 4.24% from $18.9 million recorded in FY2023.
  • Maravai Lifesciences Holdings' Prepaid Assets' 5-year high stood at $25.8 million during FY2022, with a 5-year trough of $11.1 million in FY2020.
  • Its 3-year average for Prepaid Assets is $21.0 million, with a median of $18.9 million in 2023.
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Prepaid Assets spiked by 77.54% in 2021 and then declined by 26.55% in 2023.
  • Yearly analysis of 5 years shows Maravai Lifesciences Holdings' Prepaid Assets stood at $11.1 million in 2020, then soared by 77.54% to $19.7 million in 2021, then surged by 30.97% to $25.8 million in 2022, then dropped by 26.55% to $18.9 million in 2023, then dropped by 4.24% to $18.1 million in 2024.